Evidence map›Paper›PMID 21873455›Full record

ArticleJournal of leukocyte biology2011

Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection.

Peer W F Karmaus, Weimin Chen, Robert B Crawford, Jack R Harkema, Barbara L F Kaplan, Norbert E Kaminski

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Anti-Infective Screening of Selected Nine Cannabinoids AgainstCurrent issues in molecular biology · 2025
    Article
  2. Article
  3. Article
  4. ΔThe Journal of pharmacology and experimental therapeutics · 2019
    Article
  5. Article
  6. A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  7. Article
  8. Review
  9. Endocannabinoids and Immunity.Cannabis and cannabinoid research · 2016
    Review
  10. Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Review
  11. Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2015
    Article
  12. Effects of Cannabinoids on T-cell Function and Resistance to Infection.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2015
    Review
  13. Review
  14. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2014
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Peer W F KarmausCell and Molecular Biology Program, Center for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA.
Weimin Chen
Robert B Crawford
Jack R Harkema
Barbara L F Kaplan
Norbert E Kaminski
Michigan State University · US

Funding

THC impairment of CD4/CD8 T cell-mediated host resistance to HIV and influenzaR01DA007908 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KAMINSKI, NORBERT E · 1992 to 2013
$3.0M
IL-2 Suppression by Endocannabinoid Activation of PPARgammaR01DA020402 · NIDA · MICHIGAN STATE UNIVERSITY · PI KAMINSKI, NORBERT E · 2005 to 2010
$1.5M
NIDA NIH HHS DA020402NIDA NIH HHS DA07908NIDA NIH HHS R01 DA007908NIDA NIH HHS R01 DA020402
6 · The paper itself

Abstract

We and others have reported that simultaneous targeted deletion of CB(1) and CB(2) resulted in exacerbation of immune reactivity, suggesting a role of endocannabinoids in down-regulating immune function. In this study, we demonstrate that APC function is enhanced specifically in the absence of CB(1) and CB(2) signaling, resulting in an exacerbated immune response phenotype. After influenza infection, CB(1)(-/-)CB(2)(-/-) mice showed more pronounced pulmonary damage, increased inflammatory cell infiltrate, inflammation, and a greater cellular immune responses compared with WT mice, as evidenced by transcriptome analysis, more robust T cell activation, and effector cell cytokine production. After direct activation in vitro, there were no differences in the percentages of cytokine-producing CD4(+) T cells between CB(1)(-/-)CB(2)(-/-) and WT mice. However, untreated CB(1)(-/-)CB(2)(-/-) mice routinely had fewer naïve T cells compared with WT, suggesting dysregulation of APC immune homeostasis. Moreover, bmDCs and AM isolated from CB(1)(-/-)CB(2)(-/-) mice exhibited a more mature phenotype, with and without TLR stimulation, and bmDCs elicited T cells more robustly than WT mice. Collectively, these findings implicate a role for CB(1) and CB(2) on APCs in regulating immune responses and immune homeostasis.

Indexed as

Immunity, CellularAnimalsAntigen-Presenting CellsDendritic CellsGene DeletionLymphocyte ActivationMiceOrthomyxoviridae InfectionsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Signal TransductionT-LymphocytesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2

Identifiers

PMID21873455
PMCPMC3206470
OpenAlexW2158816152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.